162 related articles for article (PubMed ID: 12786817)
1. Expression of T-cell activation marker CD134 (OX40) in lymphomatoid papulosis.
Gniadecki R; Rossen K
Br J Dermatol; 2003 May; 148(5):885-91. PubMed ID: 12786817
[TBL] [Abstract][Full Text] [Related]
2. The T-cell activation markers CD30 and OX40/CD134 are expressed in nonoverlapping subsets of peripheral T-cell lymphoma.
Jones D; Fletcher CD; Pulford K; Shahsafaei A; Dorfman DM
Blood; 1999 May; 93(10):3487-93. PubMed ID: 10233901
[TBL] [Abstract][Full Text] [Related]
3. CD30 antigen expression in cutaneous inflammatory infiltrates of scabies: a dynamic immunophenotypic pattern that should be distinguished from lymphomatoid papulosis.
Gallardo F; Barranco C; Toll A; Pujol RM
J Cutan Pathol; 2002 Jul; 29(6):368-73. PubMed ID: 12135469
[TBL] [Abstract][Full Text] [Related]
4. Single-cell analysis of CD30+ cells in lymphomatoid papulosis demonstrates a common clonal T-cell origin.
Steinhoff M; Hummel M; Anagnostopoulos I; Kaudewitz P; Seitz V; Assaf C; Sander C; Stein H
Blood; 2002 Jul; 100(2):578-84. PubMed ID: 12091351
[TBL] [Abstract][Full Text] [Related]
5. Expression of chemokines and chemokine receptors in cutaneous CD30+ lymphoproliferative disorders.
Yamaguchi T; Ohshima K; Karube K; Kawano R; Nakayama J; Suzumiya J; Kikuchi M
Br J Dermatol; 2006 May; 154(5):904-9. PubMed ID: 16634894
[TBL] [Abstract][Full Text] [Related]
6. Fascin expression in CD30-positive cutaneous lymphoproliferative disorders.
Kempf W; Levi E; Kamarashev J; Kutzner H; Pfeifer W; Petrogiannis-Haliotis T; Burg G; Kadin ME
J Cutan Pathol; 2002 May; 29(5):295-300. PubMed ID: 12100631
[TBL] [Abstract][Full Text] [Related]
7. The dominant T cell clone is present in multiple regressing skin lesions and associated T cell lymphomas of patients with lymphomatoid papulosis.
Chott A; Vonderheid EC; Olbricht S; Miao NN; Balk SP; Kadin ME
J Invest Dermatol; 1996 Apr; 106(4):696-700. PubMed ID: 8618007
[TBL] [Abstract][Full Text] [Related]
8. Killer cell immunoglobulin-like receptor expression delineates in situ Sézary syndrome lymphocytes.
Wechsler J; Bagot M; Nikolova M; Parolini S; Martin-Garcia N; Boumsell L; Moretta A; Bensussan A
J Pathol; 2003 Jan; 199(1):77-83. PubMed ID: 12474229
[TBL] [Abstract][Full Text] [Related]
9. Lymphomatoid papulosis associated with mycosis fungoides: clinicopathological and molecular studies of 12 cases.
Gallardo F; Costa C; Bellosillo B; Solé F; Estrach T; Servitje O; García-Muret MP; Barranco C; Serrano S; Pujol RM
Acta Derm Venereol; 2004; 84(6):463-8. PubMed ID: 15844638
[TBL] [Abstract][Full Text] [Related]
10. Increased risk of lymphoid and nonlymphoid malignancies in patients with lymphomatoid papulosis.
Wang HH; Myers T; Lach LJ; Hsieh CC; Kadin ME
Cancer; 1999 Oct; 86(7):1240-5. PubMed ID: 10506709
[TBL] [Abstract][Full Text] [Related]
11. [Lymphomatoid papulosis].
Dreno B
Presse Med; 1995 Jun; 24(23):1084-7. PubMed ID: 7567810
[TBL] [Abstract][Full Text] [Related]
12. Expression of cutaneous lymphocyte-associated antigen and TIA-1 by lymphocytes in pityriasis lichenoides et varioliformis acuta and lymphomatoid papulosis: immunohistochemical study.
Jang KA; Choi JC; Choi JH
J Cutan Pathol; 2001 Oct; 28(9):453-9. PubMed ID: 11553311
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous CD30+ lymphoproliferative disorders: expression of bcl-2 and proteins of the tumor necrosis factor receptor superfamily.
Paulli M; Berti E; Boveri E; Kindl S; Bonoldi E; Gambini C; Rosso R; Borroni G; Straccapansa V; Magrini U; DeCoteau JE; Krammer PH; Möller P; Kadin ME
Hum Pathol; 1998 Nov; 29(11):1223-30. PubMed ID: 9824099
[TBL] [Abstract][Full Text] [Related]
14. Lymphomatoid papulosis associated with mycosis fungoides: a study of 21 patients including analyses for clonality.
Zackheim HS; Jones C; Leboit PE; Kashani-Sabet M; McCalmont TH; Zehnder J
J Am Acad Dermatol; 2003 Oct; 49(4):620-3. PubMed ID: 14512906
[TBL] [Abstract][Full Text] [Related]
15. Expression of a Hodgkin and Reed-Sternberg cell associated antigen (Ki-1) in cutaneous lymphoid infiltrates.
Ralfkiaer E; Bosq J; Gatter KC; Schwarting R; Gerdes J; Stein H; Mason DY
Arch Dermatol Res; 1987; 279(5):285-92. PubMed ID: 2820316
[TBL] [Abstract][Full Text] [Related]
16. Three cases of lymphomatoid papulosis with a CD56+ immunophenotype.
Flann S; Orchard GE; Wain EM; Russell-Jones R
J Am Acad Dermatol; 2006 Nov; 55(5):903-6. PubMed ID: 17052504
[TBL] [Abstract][Full Text] [Related]
17. Large atypical cells of lymphomatoid papulosis are CD56-negative: a study of 18 cases.
Harvell J; Vaseghi M; Natkunam Y; Kohler S; Kim Y
J Cutan Pathol; 2002 Feb; 29(2):88-92. PubMed ID: 12150138
[TBL] [Abstract][Full Text] [Related]
18. Th2 cytokine mRNA expression in primary cutaneous CD30-positive lymphoproliferative disorders: successful treatment with recombinant interferon-gamma.
Yagi H; Tokura Y; Furukawa F; Takigawa M
J Invest Dermatol; 1996 Dec; 107(6):827-32. PubMed ID: 8941669
[TBL] [Abstract][Full Text] [Related]
19. Lymphomatoid papulosis in association with mycosis fungoides: a study of 15 cases.
Basarab T; Fraser-Andrews EA; Orchard G; Whittaker S; Russel-Jones R
Br J Dermatol; 1998 Oct; 139(4):630-8. PubMed ID: 10025972
[TBL] [Abstract][Full Text] [Related]
20. CD30/Ki-1-positive lymphoproliferative disorders of the skin--clinicopathologic correlation and statistical analysis of 86 cases: a multicentric study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group.
Paulli M; Berti E; Rosso R; Boveri E; Kindl S; Klersy C; Lazzarino M; Borroni G; Menestrina F; Santucci M
J Clin Oncol; 1995 Jun; 13(6):1343-54. PubMed ID: 7751878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
